Product Information
METHYLPREDNISOLONE SS 125 MG is a generic product labeled by Fresenius Kabi USA, LLC, priced at $3.2655 per EA under NDC 63323025803. Its NADAC has been published 68 times since Jun 18, 2025.
FDA first approved this application on Jul 30, 2004. Its Orange Book therapeutic-equivalence code is AP.
Strength
125 mg/2mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323025803
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONE SODIUM SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA040583FDA Approved
7/30/2004
TE Code
AP
On Market Since
11/30/2004
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE SS 125 MG has been published 68 times since Jun 18, 2025, and over the history we have for it it has risen 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2655 per EA |
|---|---|
| All-time high | $4.1391 (May 13, 2026) |
| All-time low | $2.8086 (Jun 18, 2025) |
| 52-week high | $4.1391 |
| 52-week low | $2.9733 |
| Median price | $3.5845 |
| Average price | $3.4907 |
| Largest weekly change | +10.2% (Jan 21, 2026) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METHYLPREDNISOLONE SODIUM SUCCINATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPREDNISOLONE SODIUM SUCCINATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE SS 125 MG?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE SS 125 MG, manufactured by Fresenius Kabi USA, LLC, is $3.2655 per EA (NDC 63323025803), effective Sep 30, 2026.
How has the price of METHYLPREDNISOLONE SS 125 MG changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE SS 125 MG has risen 16.3%. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE SS 125 MG?
Since Jun 18, 2025, the NADAC for METHYLPREDNISOLONE SS 125 MG has ranged from a low of $2.8086 (Jun 18, 2025) to a high of $4.1391 (May 13, 2026), with a median of $3.5845 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE SS 125 MG?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPREDNISOLONE SS 125 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPREDNISOLONE SS 125 MG?
METHYLPREDNISOLONE SS 125 MG (NDC 63323025803) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.